Opus Genetics, Inc. (IRD) stock
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30483% above fair value
$4.06−0.25 (-5.80%)
Close on Nov 12, 2026Market cap $337.78MP/E –Yield –
Opus Genetics statistics
77 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 9, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 8.79
- 2.29
Enterprise valuationIndustry
- EV / Sales
- 31.44
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 92.0%
- 10.9%
- Shares Change (QoQ)
- 15.9%
- 0.48%
- Float
- 52M
- 49M
- Shares Held by Insiders
- 37.6%
- 12.1%
- Shares Held by Institutions
- 72.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 11M
- –
- Short Interest Change
- -18.5%
- -0.76%
- Short % of Float
- 20.9%
- 9.06%
- Short % of Shares Outstanding
- 13.1%
- 6.30%
- Days to Cover
- 8.38
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $7.07
- –
- 52-Week Low
- $1.70
- –
- 20-Day Moving Average
- $3.89
- –
- 50-Day Moving Average
- $4.50
- –
- 200-Day Moving Average
- $4.26
- –
- Average True Range (14)
- $0.32
- –
- Price Change (1 Week)
- 1.37%
- 1.51%
- Price Change (1 Month)
- -0.98%
- -2.37%
- Price Change (3 Months)
- 12.5%
- -21.1%
- Price Change (6 Months)
- -18.3%
- -22.8%
- Price Change (YTD)
- 102.0%
- -22.6%
- Price Change (1 Year)
- 106.1%
- -21.0%
- Price Change (3 Years)
- 41.0%
- -24.8%
- Price Change (5 Years)
- 1.50%
- -76.9%
- Price Change (10 Years)
- -95.0%
- -63.2%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 1M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.67
- 0.80
- Relative Strength Index (14)
- 49.1
- 44.7
- Volatility (1 Year)
- 81.2%
- 80.2%
- Beta (5 Years)
- 0.97
- 1.07
MarginsIndustry
- Pretax Margin
- -1726.7%
- -11.8%
- EBITDA Margin
- -777.7%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -615.6%
- -51.3%
- Return on Assets (ROA)
- -208.0%
- -40.7%
- Return on Capital Employed (ROCE)
- -72.0%
- -38.1%
Financial positionIndustry
- Current Ratio
- 9.65
- 3.31
- Quick Ratio
- 9.15
- 2.41
- Interest Coverage
- -217.47
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- -45.9%
- 7.26%
- Revenue Growth (3Y CAGR)
- -29.1%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.12
- 0.40
- Revenue Per Employee
- $293.11K
- $429.38K
- Profits Per Employee
- -$5.06M
- -$683.67K
- Employee Count
- 27
- 75
- WACC
- 9.75%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- -$136.65M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $88.97M
- $16.98M
- Net Cash Per Share
- $1.07
- $0.72
- Equity (Book Value)
- $38.43M
- $52.68M
- Book Value Per Share
- $0.46
- $1.50
- Tangible Book Value
- $38.43M
- $26.74M
- Working Capital
- $85.02M
- $78.52M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -40.5%
- -21.0%
- Buyback Yield
- -0.72%
- -0.73%
- Shareholder Yield
- -0.72%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $283.00K
- $2.97M
- Income Tax
- $0
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -1.95
- 0.26
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | IRD | S&P 500 | Difference | IRD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -12.5% | -2.7% | −9.8 pts | ||
| 3 months | +8.0% | -1.7% | +9.7 pts | ||
| Year to date | +102.0% | +11.9% | +90.1 pts | ||
| 1 year | +111.5% | +12.0% | +99.5 pts | ||
| 3 years | +43.5% | +78.2% | −34.7 pts | +12.8% | +21.2% |
| 5 years | +1.5% | +73.2% | −71.7 pts | +0.3% | +11.6% |
| 10 years | -95.0% | +309.6% | −404.7 pts | -25.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
11M IRD shares were sold short on Oct 30, 2026, down 18.5% from the previous report, or 20.94% of the shares available to trade. At recent volumes it would take 8.4 days to buy them back. Over the last 20 sessions, 58.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 10,864,249 | -18.5% | 1,297,061 | 8.4 |
| Oct 15, 2026 | 13,337,904 | +2.5% | 1,798,991 | 7.4 |
| Sep 30, 2026 | 13,013,222 | +3.5% | 2,150,972 | 6.0 |
| Sep 15, 2026 | 12,578,772 | +15.3% | 8,352,775 | 1.5 |
| Aug 31, 2026 | 10,912,085 | -3.0% | 878,186 | 12.4 |
| Aug 14, 2026 | 11,248,349 | +3.7% | 733,903 | 15.3 |
| Jul 31, 2026 | 10,848,529 | +5.7% | 908,931 | 11.9 |
| Jul 15, 2026 | 10,265,963 | +24.8% | 820,063 | 12.5 |
| Jun 30, 2026 | 8,228,353 | +43.4% | 1,568,617 | 5.3 |
| Jun 15, 2026 | 5,737,860 | +46.5% | 806,434 | 7.1 |
| May 29, 2026 | 3,917,871 | +26.0% | 807,581 | 4.8 |
| May 15, 2026 | 3,109,049 | +55.5% | 971,585 | 3.2 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?